Metabolomics, a modern branch of chemical biology, provides qualitative and quantitative information about the metabolic states of organisms or cells at the molecular level. Here we report non-targeted, metabolomic analyses of human blood, using liquid chromatography-mass spectrometry (LC-MS). We compared the blood metabolome to the previously reported metabolome of the fission yeast, Schizosaccharomyces pombe. The two metabolomic datasets were highly similar: 101 of 133 compounds identified in human blood (75%) were also present in S. pombe, and 45 of 57 compounds enriched in red blood cells (RBCs) (78%) were also present in yeast. The most abundant metabolites were ATP, glutathione, and glutamine. Apart from these three, the next most abundant metabolites were also involved in energy metabolism, anti-oxidation, and amino acid metabolism. We identified fourteen new blood compounds, eight of which were enriched in RBCs: citramalate, GDP-glucose, trimethyl-histidine, trimethylphenylalanine, trimethyl-tryptophan, trimethyl-tyrosine, UDP-acetyl-glucosamine, UDP-glucuronate, dimethyl-lysine, glutamate methyl ester, N-acetyl-(iso)leucine, N-acetyl-glutamate, N 2 -acetyl-lysine, and N 6 -acetyl-lysine. Ten of the newly identified blood metabolites were also detected in S. pombe, and ten of the 14 newly identified blood metabolites were methylated or acetylated amino acids. Trimethylated or acetylated free amino acids were also abundant in white blood cells. It may be possible to investigate their physiological roles using yeast genetics.
Introduction
Metabolomics is a rapidly growing branch of comprehensive, post-genomic, quantitative chemical biology. [1] [2] [3] [4] [5] It aims to profile small molecules present in living organisms, and is now recognized as an important tool for studying metabolic regulation in a synthetic way, together with transcriptomic and proteomic analyses. 6 Mass spectrometry (MS), a highly sensitive molecular detection method, can reveal thousands of intracellular metabolites over a very broad range of concentrations. However, the number of identified, named compounds is surprisingly small.
One reason is the paucity of commercially available standards. Second, it is difficult to identify unknown ions, due to the limited structural information that can be obtained using MS. Third, the concentrations of many metabolites present in biological samples are very low, and they tend to undergo changes during sample preparation. Hence fewer than several hundred relatively abundant compounds are usually reported in comprehensive metabolomic studies. [7] [8] [9] Red blood cells (RBCs or erythrocytes) deliver oxygen to tissues and remove carbon dioxide. In humans, approximately 5 L of blood circulates through the whole body per minute. 10 In healthy individuals, RBCs comprise 45% of the blood volume, and the remainder is mostly plasma, with a tiny additional fraction of leucocytes or white blood cells (WBCs). Plasma contains proteins (e.g. albumins, globulins, fibrinogen, etc.), electrolytes, hormones, glucose, and other metabolites. Mammalian RBCs exclude nuclei, mitochondria, and other prominent cell organelles, such as lysosomes, endoplasmic reticulum, and Golgi bodies during erythropoiesis in the bone marrow. Mature, simplified and specialized for gas transfer, RBCs have no demonstrable protein synthesis, nor tricarboxylic acid (TCA) cycle activity. 11 Nevertheless, RBCs produce adenosine triphosphate (ATP) glycolytically, maintain redox homeostasis, and osmoregulate. 12 Human RBCs have a relatively long life span of about 120 days. 13 When senescent, they are captured by the spleen for degradation. Numerous blood metabolomic analyses have been previously reported, mostly of serum and plasma. [14] [15] [16] [17] [18] [19] However, metabolomics of whole blood or RBCs have been less well investigated, except for several reports on long-term stored blood, [20] [21] [22] [23] blood of disease patients, 24, 25 or blood marker compounds of food intake. 26 Reports on the WBC metabolome are scarce. 27, 28 This study focuses on the metabolome of blood cells, mainly RBCs, separated from plasma by low speed centrifugation. We also briefly investigated the metabolome of WBCs prepared by Ficoll gradient centrifugation, to compare it with that of RBCs. The fission yeast, Schizosaccharomyces pombe, a eukaryotic microbe with a genome encoding only B5000 genes, 29, 30 is an excellent model organism to study nutritional control of the transition between proliferation and quiescence (e.g. Yanagida et al. 31 ). We have employed metabolomic analysis of S. pombe cells in order to understand cellular metabolic states under different nutritional regimes and as governed by different genotypes. Initially, we reported the identification of 123 compounds using liquid chromatography-mass spectrometry (LC-MS) and their changes following heat stress and genetic perturbations. 8 We described the accumulation of antioxidants, glutathione, and ergothioneine in a proteasome regulatory subunit mutant mts3-1. 32 Also we made targeted measurements of intermediates of the coenzyme A biosynthetic pathway from pantothenate, 33 investigated changes in the cellular metabolome upon glucose 34 and nitrogen starvation, 35 and accumulation of various metabolites in the quiescence-defective Dklf1 mutant. 36 These studies showed that S. pombe may be used as a model organism to study comprehensive metabolic patterns under defined genetic and physiological conditions. S. pombe cells grow and divide in culture media containing only 0.08% glucose as rapidly as in regular synthetic culture media containing 2% glucose; however, their division rate is impaired if extracellular glucose drops below 0.08% 34 (4.4 mM), a concentration that is roughly equivalent to that in the blood of healthy humans before breakfast. That the glucose concentration required to sustain life is roughly equivalent between such diverse eukaryotes is remarkable. In this study we report further significant conservation in metabolites between evolutionarily distant human RBCs and S. pombe vegetative cells.
Results

Preparation and analysis of human blood metabolomic samples
Blood samples (4-5 mL) for metabolomic analysis were collected from healthy volunteers before breakfast (schematized in Fig. 1A , Materials and methods). WBCs stained with Giemsa ( Fig. 1B) were infrequently observed (o1%) in blood. WBCs were not removed, since rapid quenching of metabolic reactions was necessary to obtain reproducible, quantitative data (Ficoll gradient centrifugation to separate WBCs is a time-consuming step). Low-molecularweight metabolites were isolated by filtration with a 10 kDa cut-off filter at 4 1C, concentrated on a rotary evaporator, re-suspended in 40 mL 50% acetonitrile, and stored at À80 1C until analysis. For LC-MS analysis, metabolites were first separated by hydrophilic interaction chromatography (ZIC-pHILIC column; Merck SeQuant), 37 and detected using an LTQ Orbitrap MS (Thermo Fisher Scientific) in full scan mode (100-1000 m/z, ratio of mass-tocharge) with both positive and negative electrospray ionization. LC-MS data contain semi-quantitative information about thousands of compounds in human blood. For compound analysis and quantification, we employed basically the same procedures used in previous analyses of S. pombe metabolites 8 (Fig. 1C) . For quantification, we integrated peak curves, obtaining peak areas in arbitrary AU units. ATP and glutathione are RBC-enriched, meaning that peak areas in the RBC fraction were at least 2-fold higher than the corresponding peaks in plasma (see 'Fifty-seven RBC-enriched compounds' below). It is difficult to obtain reproducible quantitative data on reduced glutathione (GSH) due to its auto-oxidation during sample preparation. For that reason, only levels of oxidized glutathione (GSSG) are reported in the present study.
Thirty-two compounds identified in human blood were not detected in yeast 40 or ChemSpider. 41 Whenever possible, the identified compounds were verified using purchased standards. In some cases, isomers (e.g. N-acetyl-leucine, N-acetyl-isoleucine; paraxanthine, theobromine, theophylline) could not be clearly distinguished by LC and were designated by more general names (e.g., N-acetyl-(iso)leucine or dimethyl-xanthine, respectively).
To identify metabolites for which standards were not available, we performed MS/MS analysis. Methyl-lysine, trimethylphenylalanine, and trimethyl-tyrosine were tentatively identified and described ( Fig. S1A -C, ESI †). We were able to identify 133 compounds in blood, representing 14 categories (Table 1) .
To compare compounds present in S. pombe with those in human blood, S. pombe cells were cultivated at 26 1C in synthetic, minimal EMM2 medium with 0.1% glucose (5.6 mM; roughly the same glucose concentration found in blood). Among 133 identified blood metabolites, 32 were not found in fission yeast (Table 1) . They include three nucleoside bases and derivatives, one coenzyme precursor (4-aminobenzoate), one nucleotide-sugar derivative (UDP-glucuronate), one sugar derivative (1,5-anhydroglucitol), two organic acids (chenodeoxycholic acid, glyceric acid), six methylated amino acids including dimethyl-proline, eight other amino acid derivatives including creatine, creatinine, and taurine, and ten carnitines. Thus, 24 of 32 compounds are derived from three categories, namely, methylated amino acids, other amino acids, and carnitines. These three categories illustrate the major difference between human blood and S. pombe metabolomes. Some compounds may play specific roles in higher eukaryotes. For example, creatine and phosphocreatine are stored in muscles as an energy source, and creatinine is the metabolic byproduct of creatine phosphate. 42 Carnitines are produced in the liver and stored in muscles for consumption and transport of fatty acids. 43 Urate is a purine metabolic byproduct, high blood concentrations of which can cause gout, 44 while caffeine is a xanthine alkaloid and of dietary origin. 45, 46 S. pombe does not produce caffeine, but can become hypersensitive or resistant to caffeine by certain mutations.
47,48
Fourteen newly identified blood compounds
To our knowledge, 14 metabolites have not hitherto been reported in human blood, based on a recent report of detected blood metabolites 49 and literature database searches (Table 1) . These new blood metabolites include citramalate, dimethyl-lysine, GDP-glucose, glutamate methyl ester, N-acetyl-glutamate, N-acetyl-(iso)leucine, N 2 -acetyl-lysine, N 6 -acetyl-lysine, trimethyl-histidine, trimethylphenylalanine, trimethyl-tryptophan, trimethyl-tyrosine, UDPacetyl-glucosamine and UDP-glucuronate. The eight compounds in boldface were enriched in RBCs, while the ten compounds in italics were also found in S. pombe. Ten of the 14 novel blood metabolites are methylated or acetylated amino acids.
Quantification of blood metabolite peaks
Each blood sample produced thousands of peaks in positive and negative ionization modes with a broad range (10 4 -10 9 AU) 
Nucleosides, nucleobases and derivatives , and 1% of all peaks, respectively. Quantitative reproducibility of peak areas was examined by collecting two blood samples independently from the same person at 1 h intervals. Each pair of samples (#1 and #2) of blood, plasma, and RBCs was compared in a scatter plot ( Fig. 2A and Fig. S2A, ESI †) . In all cases, 85-87% of peak areas varied less than 2-fold (0.5-2.0Â). Fission yeast samples obtained under identical conditions showed similar reproducibility. 8 Very small peaks (area o10 6 AU) showed larger deviations. For 133 compounds identified in blood, plasma or RBCs, however, 97% of peaks in the compared samples changed less than 2-fold ( Fig. 2B and Fig. S2B , ESI †). Thus, in both blood and fission yeast metabolomes, quantitative reproducibility was better for identified peaks. . ATP produced these two peaks as its highest signals (Fig. 2C) . ATP also produced 16 additional peaks (6 in positive and 10 in negative mode). Since their retention time (RT) was basically identical to that of the corresponding primary peak, we suspect that these additional peaks were produced during ionization in the MS. For ergothioneine, 17 peaks were identified in addition to the primary peaks (Fig. S2C, ESI †) .
In blood samples we were able to identify 37 (74%) peaks in group H, 118 (33%) peaks in group M, and 518 peaks (11%) in group L. The total number of assigned peaks (673) is much larger than that of actually identified compounds (133), due to the fact that many metabolites produced multiple peaks. A number of peaks were also produced by electrolytes such as NH 4 Cl, originating from NaCl in blood samples. While several thousand peaks were obtained by LC-MS, the actual number of compounds that can be detected in blood may be much less, possibly B1000.
Fifty-seven RBC-enriched compounds
To determine the degree of compound enrichment in RBCs vs. plasma, samples of both were prepared from the same blood donor several times. We designate RBC-enriched compounds as those having an RBC : plasma ratio more than 2.0 ( Fig. 2D and Table 1 ; detailed annotation of all peaks in Fig. S3, ESI †) .
ATP and glutathione showed particularly large peak areas (410 8 AU) in the RBC sample, but much smaller in the plasma sample (RBC : plasma ratios of 81 and 1900, respectively). In contrast, carnitine and urate showed RBC : plasma ratios of 0.85 and 0.69, respectively, even though their peak areas were large (410 8 AU) in both samples.
Fifty-seven compounds were enriched in RBCs (Table 1) Fig. 2 Quantification of peak area reproducibility examined by a scatter plot. Blood was donated twice by the same person in 1 h, and the two blood samples were processed separately (samples #1 and #2). (A) Scatter plot of all peaks detected in both blood samples (positive and negative ionization modes combined). 87% of peaks differed less than 2-fold. Less than 15% of these peaks could be assigned to a known compound (assigned peaks marked yellow). (B) A scatter plot of 129 identified compounds detected in blood samples #1 and #2. Approximately 97% of these peaks were found within 2-fold change. (C) Multiple peaks are produced by abundant compounds such as ATP. In addition to the primary singly charged ions (indicated by arrows), compounds produce multiply charged ions, fragments of the molecule, adducts with salts, and complexes with other compounds eluting at similar retention times. We were able to identify 18 peaks related to ATP, listed in the inset table. (D) RBC and plasma samples were prepared from the same person, and the peak areas were determined for identified compounds, and compared in a scatter plot.
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compounds (S-adenosyl-homocysteine, S-methyl-ergothioneine, tetradecanoyl-carnitine, trimethyl-histidine) and N-acetyl-Dglucosamine. There was no evidence of leakage of these highly enriched compounds from RBCs, confirming that cells were not damaged during handling. Metabolites moderately enriched in RBCs (RBC : plasma ratio between 2 and 30) contain compounds from the categories mentioned above, as well as nucleotidesugar derivatives and at least one or two compounds from other categories (except antioxidants and choline derivatives). Many RBC-enriched compounds, such as nucleotides and sugar-phosphates, are involved in RBC metabolic pathways. 23 Others such as acetyl-carnitine 50 and trimethyl-lysine 51 were previously reported to be enriched in RBCs, but their origins and roles in RBCs are unknown. Interestingly, eight of the fourteen newly discovered blood components (nucleotide-sugar derivatives and methylated amino acids) were also enriched in RBCs. In contrast to RBC-enriched compounds, adenosine, guanosine, and inosine were scarcely detected in RBCs. Thus, brief centrifugation to sediment RBCs in combination with LC-MS quantification enabled us to classify metabolites into several groups based upon their RBC : plasma ratios (430 highly RBCenriched, o30, 42 RBC-enriched; o2 present in both plasma and RBC).
Comparison of semi-quantified metabolites between blood and S. pombe
Some compounds exhibited similar abundance in blood and S. pombe cells (Table 1) . ATP (H), ADP (M), AMP (M) and GTP (M) were similar in both, whereas UTP was abundant in S. pombe (H), but not in blood (L). Except for UTP, these nucleotides are enriched in RBC; thus RBCs evidently have a low requirement for UTP, since RNA synthesis does not occur in RBCs. Diphospho-glycerate, an allosteric regulator of hemoglobin present at mM concentrations in RBCs, 52 was highly abundant (H) in blood, but not in S. pombe (L). Pentosephosphate and sedoheptulose-7-phosphate were more abundant in S. pombe (M) than in blood (L), indicating that growing and dividing yeast cells require greater amounts of pentose phosphate pathway intermediates. Seventeen regular and seven acetylated amino acids were commonly present in blood and yeast. Fourteen methylated amino acids were significantly different between blood and S. pombe, while seven methylated amino acids (betaine, dimethyl-arginine, dimethyl-lysine, methyl-histidine, methyllysine, trimethyl-histidine, trimethyl-lysine) were commonly present in both, and seven others (butyro-betaine, dimethylproline, S-methyl-ergothioneine, trimethyl-phenylalanine, trimethyl-tryptophan, trimethyl-tyrosine) were detected only in human samples. Three anti-oxidants, glutathione, ergothioneine, and ophthalmic acid, were present in both human and yeast samples.
Eighteen S. pombe compounds not detected in human blood
Eighteen compounds present in S. pombe were not detected in RBCs or in plasma ( (Table S1 , ESI †). Differences between the two are mainly the types of vitamins and coenzymes. 4-Aminobenzoate was detected in blood and RBCs, but not in WBCs. Acetyl-CoA, biotin, FAD, and HMG-CoA, described above, belong to the coenzyme category. Seven compounds, which seem to be mainly involved in cell growth and division in eukaryotes, were found in both WBCs and S. pombe (Table S1 , ESI †).
Summary and categorization of detected blood compounds
Human blood metabolites identified in this study are summarized in Fig. 3 . Three nucleosides, adenosine, guanosine and inosine, may be restricted to plasma, as RBC : plasma ratios are close to zero (Table 1) . cis-Aconitate (0.3), citrate (0.3), indoxylsulfate (0.4), kynurenine (0.4), N-acetyl-arginine (0.3), and quinolinic acid (0.4) appear to be found primarily in plasma. In contrast, NADP + , S-adenosyl-homocysteine, phosphoenolpyruvate, glutathione disulfide (GSSG), diphospho-glycerate, and fructose-1,6-diphosphate were highly enriched in RBC fractions. Their RBC : plasma ratios are rather large (41000). RBC compounds of intermediate abundance (ratio 450-o1000) included 6-phosphogluconate, ADP, AMP, ATP, ergothioneine, GTP, IMP, NAD + , NADPH, ophthalmic acid, phosphoglycerate, S-methyl-ergothioneine, tetradecanoyl-carnitine, and trimethylhistidine. All other compounds are presumably present in both RBCs and plasma.
Energy and anti-oxidant metabolites abundant in human blood and fission yeast Some compounds (ATP, glutathione and glutamine) were highly abundant in both RBCs and S. pombe (Fig. 4) . Most compounds in the high and medium categories are implicated in energy metabolism, anti-oxidation, or amino acid metabolism. In the WBC metabolome (Table S2 , ESI †), ATP, glutathione, and glycerophosphocholine (instead of glutamine) were abundant. Some medium-level compounds (e.g. NAD + and UDP-glucose) are required for production of highenergy compounds such as ATP, GTP, and UTP. Ergothioneine and ophthalmic acid are thought to be anti-oxidants. It thus appears that energy metabolites, anti-oxidants, and amino acid metabolites may be the most highly conserved in eukaryotes.
Discussion
In the present study we performed LC-MS-based metabolomic analysis of human blood, plasma, and RBCs in comparison with previously published metabolomic results from the fission yeast, S. pombe. 8, 34 Analysis of the S. pombe metabolome was performed simultaneously, and results were consistent with those of previous reports. This comparative study enabled us to learn which metabolomic features are conserved between these distantly related cellular systems. The LC column we employed (76), based on whether the ratios of their RBC : plasma peak areas were either 42 or o2, respectively ( Table 1) . Abundance of compounds classified by peak area size, indicated by color, red (high), green (medium) and blue (low). Compounds with the statue symbol are not present in S. pombe. See text for details.
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can separate hydrophilic compounds with high resolution, but is not appropriate for separating hydrophobic compounds; therefore, our data contain limited information on lipids, except for two choline derivatives, CDP-choline and glycerophosphocholine. For this reason, conclusions regarding metabolite conservation should be restricted to hydrophilic compounds. Thirty-two compounds were found in blood, but not in S. pombe (Fig. 3) . Metabolite compositions of blood and fission yeast are unexpectedly similar, with 75% identified compound in blood also present in fission yeast. The WBC metabolome is also highly similar to those of RBCs and yeast. However, metabolites mostly belonging to three categories (ten carnitines, six methylated amino acids, eight other amino acid derivatives) were not detected in S. pombe (Table 1) . If we compare metabolites in the remaining 11 categories, only 8 of 89 compounds were not present in S. pombe (caffeine, dimethyl-xanthine, urate, 4-aminobenzoate, UDP-glucuronate, 1,5-anhydroglucitol, chenodeoxycholic acid, and glyceric acid); therefore the overall similarity between the two metabolomes is 90% (81/89 Â 100). Differences are mostly restricted to carnitines and amino acid derivatives.
Among the fifteen high abundance blood compounds, however, S. pombe lacks six (40%) metabolites (acetylcarnitine, carnitine, creatine, dimethyl-proline, trimethyltryptophan and urate), indicating that the most abundant compounds in blood are quite different from those of S. pombe. Conversely, among the 14 high abundance S. pombe compounds, only 2 (trehalose, ferrichrome) were not present in human blood, indicating that 86% are also found in human blood. We presume that the high abundance metabolites of S. pombe may be more 'fundamental' than those of blood, since S. pombe is a single-celled eukaryote. Blood contains a multitude of specialized metabolites. Carnitine is not strictly a metazoan compound, as it is also synthesized from lysine in Neurospora. 61 However, a great variety of carnitine derivatives (9) carrying different fatty acids might be a feature of higher eukaryotes.
The high similarity of these two metabolomes raises the possibility that S. pombe genetics might be useful to understand the role of certain metabolites, such as small anti-oxidants (ophthalmic acid, ergothioneine, and glutathione), which are enzymatically synthesized in S. pombe. S-Adenosyl-homocysteine (SAH) and S-adenosyl-methionine (SAM), coenzymes involved in the methionine cycle, were also enriched in RBCs. S-Adenosylmethionine synthase has been reported in RBCs. 62 In RBCs, SAM has been shown to act as a coenzyme for protein carboxyl methylation, 63 synthesis of phosphatidylcholine, 64 and N-, Oand S-methyltransferase activities (reviewed by Weinshilboum et al.
65
). It remains to be determined how SAH and SAM in RBCs are involved in the production of methylated compounds. We are particularly interested in determining whether the levels of free methylated amino acids are controlled by SAM and SAH. To this end, we isolated a number of S. pombe mutants of methionine cycle enzymes and their metabolic profiles are being examined (T. Hayashi et al., unpublished results).
We found 14 novel human blood compounds, eight of which were methylated or N-acetylated amino acids. To our knowledge, there has been no report describing these as blood components. Blood data presented in this report came from four healthy volunteers. We further extended our analysis to more than 30 people (Chaleckis et al., manuscript in preparation), and these compounds were universally present, suggesting that their occurrence is neither accidental nor specific to certain dietary customs. Interestingly, eight of these compounds (UDP-acetylglucosamine, citramalate, dimethyl-lysine, trimethyl-histidine, N-acetyl-glutamate, N 2 -acetyl-lysine, N 6 -aceltyl-glutamate and glutamate methyl ester) were also present in S. pombe. Their physiological roles can thus be further investigated using S. pombe as a model. Seven of the eight compounds are RBCenriched. RBCs may require UDP-acetyl-glucosamine, a nucleotide sugar and a coenzyme, as a signaling molecule of sugar metabolism, like in other eukaryotic cells, including S. pombe.
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UDP-glucuronic acid is synthesized in the liver, binds to hormones or toxic compounds, and is also used for the synthesis of glucuronic acid-containing polysaccharides. 67, 68 It is not present in lower eukaryotes. Citramalate is an intermediate in bacterial glutamate degradation. 69 Citramalate and glutamate methyl-ester are also present in S. pombe, but their physiological role is not understood. Two acetylated amino acids, N 2 -acetyl-lysine and N 6 -acetyl-lysine, are present in plasma and RBCs, as well as in S. pombe, but their biological role is little understood. N-acetyl-glutamate is involved in the removal of waste from the body in the urine as it is an allosteric cofactor of carbamoyl phosphate synthetase I, the first enzyme in the urea cycle. 70 Five novel blood compounds are methylated amino acids, four (histidine, phenylalanine, tryptophan, tyrosine) of which are trimethylated and enriched in RBCs. Trimethyl-histidine (hercynine) is a precursor of ergothioneine, but humans do not synthesize ergothioneine; therefore this compound might be of dietary origin or possibly a degradation product of ergothioneine, 71 whereas S. pombe can produce it. 34, 35 Trimethyltryptophan (hypaphorine) was highly abundant in RBCs. It has been reported that this compound has soporific 72 and
anti-glycemic effects in mice. 73 Hypaphorine was reported in human milk following maternal consumption of legumes. 74 ATP and glutathione were selectively enriched in RBCs (scarcely present in plasma), while glutamine was found in both plasma and RBCs in roughly equal amounts. Eleven sugar phosphate compounds required for sugar and energy metabolism were all found in RBC-enriched fractions and also in S. pombe. Similarly, all twelve nucleotides, four nucleotide-sugar derivatives, and five coenzyme NAD-related compounds were selectively enriched in RBCs. Fifty-six percent of RBC-enriched compounds are energy-related; these compounds are also found in S. pombe. Three anti-oxidant compounds, glutathione, ergothioneine, and ophthalmic acid, were enriched in RBCs and abundant in S. pombe. Glutathione and ophthalmic acid may be synthesized in RBCs, as the synthetic enzymes encoded by the human genes are present in RBCs. 75 Aspartate and glutamate were selectively enriched in RBCs. Both are excitatory neurotransmitters. Inhibitory transmitters, GABA and glycine, are difficult to measure using our method. Glutamate may be partly utilized for the synthesis of glutathione. 76 These energy and antioxidant compounds are most likely essential for maintaining RBCs during their relatively long lifespan of 120 days, and these compounds are also common to S. pombe.
Materials and methods
Chemicals and reagents
Standards for metabolite confirmation were obtained from various vendors (Table S3 , ESI †), depending on the compound. Ergothioneine and S-methyl-ergothioneine were a kind gift from Tetrahedron, France.
Human subject characteristics
Three healthy male and one female volunteers (23-33 years old) participated in this study. Blood samples for metabolomic analysis were taken in the morning and subjects were asked not to eat breakfast to ensure at least 12 h of fasting prior to sampling.
Ethics statement
Written informed consent was obtained from all donors in accordance with the Declaration of Helsinki. All experiments were performed in compliance with relevant Japanese laws and institutional guidelines. respectively, was quenched in 1.8 mL of 55% methanol at À40 1C. Ten nmol each of HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) and PIPES (piperazine-N,N 0 -bis(2-ethanesulfonic acid)) was added to each sample to serve as standards. After brief vortexing, the samples were transferred to Amicon Ultra 10 kDa cut-off filters (Millipore, Billerica, MA, USA) to remove proteins and cell debris. Following sample concentration by vacuum evaporation, each sample was re-suspended in 40 mL of 50% acetonitrile and 1 mL (equivalent to 5 mL of initial sample) was used for each injection into the LC-MS system.
Isolation of leucocytes by Ficoll gradient centrifugation
For isolation of leucocytes we employed Ficoll gradient centrifugation. Blood of two donors, 20 mL each, was collected into heparinized tubes (Terumo) and subsequently diluted with the same volume of PBS buffer. Diluted blood was carefully layered onto the same volume of Lympholyte-H (Cosmo Bio, Tokyo, Japan) and centrifuged at room temperature for 20 min at 800 Â g. Separated leucocytes were washed 3Â in PBS (1 min, 350 Â g, 4 1C). After dilution, 0.2 mL of leucocytes (B5 Â 10 7 cells) was quenched in 1.8 mL of 55% methanol at À40 1C.
After the addition of HEPES and PIPES, samples were processed as described above. Metabolites were isolated from 10 mL of leukocyte cell volume (assuming an individual leukocyte cell volume of 200 fL 77 and an estimated 5 Â 10 7 cells per sample). One mL of the metabolome sample was injected into the LC-MS system, corresponding to B0.25 mL of leukocyte intracellular volume.
Fission yeast growth conditions and preparation for metabolomics analysis
The wild-type heterothallic haploid 972 h À S. pombe strain 78 was used for metabolomic experiments. Cells were cultivated at 26 1C in minimal synthetic medium EMM2 79 with 0.1% glucose (5.6 mM) content. Limited glucose media were prepared by mixing regular EMM2 (2% glucose) medium with EMM2-G (0% glucose) in an appropriate ratio. Preparation of fission yeast samples was done as described previously. 8 Metabolites were isolated from 30 mL of total S. pombe cell volume (S. pombe cell diameter 3.5 mm; 80 cells grown at 5.6 mM glucose have lengths of 13 mm, 34 and thus using a formula from Mitchison, 80 the mean cell volume is 120 fL; total number of cells per sample
